Literature DB >> 23398560

Sulfation patterns determine cellular internalization of heparin-like polysaccharides.

Karthik Raman1, Caitlin Mencio, Umesh R Desai, Balagurunathan Kuberan.   

Abstract

Heparin is a highly sulfated polysaccharide that serves biologically relevant roles as an anticoagulant and anticancer agent. While it is well-known that modification of heparin's sulfation pattern can drastically influence its ability to bind growth factors and other extracellular molecules, very little is known about the cellular uptake of heparin and the role sulfation patterns serve in affecting its internalization. In this study, we chemically synthesized several fluorescently labeled heparins consisting of a variety of sulfation patterns. These polysaccharides were thoroughly characterized using anion exchange chromatography and size exclusion chromatography. Subsequently, we utilized flow cytometry and confocal imaging to show that sulfation patterns differentially affect the amount of heparin uptake in multiple cell types. This study provides the first comprehensive analysis of the effect of sulfation pattern on the cellular internalization of heparin or heparan sulfate like polysaccharides. The results of this study expand current knowledge regarding heparin internalization and provide insights into developing more effective heparin-based drug conjugates for applications in intracellular drug delivery.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23398560      PMCID: PMC3685167          DOI: 10.1021/mp300679a

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  32 in total

1.  Control of angiogenesis with synthetic heparin substitutes.

Authors:  J Folkman; P B Weisz; M M Joullié; W W Li; W R Ewing
Journal:  Science       Date:  1989-03-17       Impact factor: 47.728

2.  Heparin inhibits A431 cell growth independently of serum and EGF mitogenic signalling.

Authors:  S Vannucchi; F Pasquali; V P Chiarugi; M Ruggiero
Journal:  FEBS Lett       Date:  1991-04-09       Impact factor: 4.124

3.  Heparin stimulation of plasminogen activator secretion by macrophage-like cell line RAW264.7: role of the scavenger receptor.

Authors:  D J Falcone
Journal:  J Cell Physiol       Date:  1989-08       Impact factor: 6.384

4.  Heparin and angiogenesis: a low-molecular-weight fraction inhibits and a high-molecular-weight fraction stimulates angiogenesis systemically.

Authors:  K Norrby
Journal:  Haemostasis       Date:  1993-03

5.  Activating and inhibitory heparin sequences for FGF-2 (basic FGF). Distinct requirements for FGF-1, FGF-2, and FGF-4.

Authors:  S Guimond; M Maccarana; B B Olwin; U Lindahl; A C Rapraeger
Journal:  J Biol Chem       Date:  1993-11-15       Impact factor: 5.157

6.  Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone.

Authors:  J Folkman; R Langer; R J Linhardt; C Haudenschild; S Taylor
Journal:  Science       Date:  1983-08-19       Impact factor: 47.728

7.  Contribution of 3-O- and 6-O-sulfated glucosamine residues in the heparin-induced conformational change in antithrombin III.

Authors:  D H Atha; J C Lormeau; M Petitou; R D Rosenberg; J Choay
Journal:  Biochemistry       Date:  1987-10-06       Impact factor: 3.162

8.  Solvolytic desulfation of glycosaminoglycuronan sulfates with dimethyl sulfoxide containing water or methanol.

Authors:  K Nagasawa; Y Inoue; T Kamata
Journal:  Carbohydr Res       Date:  1977-09       Impact factor: 2.104

9.  Effect of heparin modification on its activity in enhancing the inhibition of thrombin by antithrombin III.

Authors:  I Danishefsky; M Ahrens; S Klein
Journal:  Biochim Biophys Acta       Date:  1977-06-23

10.  Transport of heparan sulfate into the nuclei of hepatocytes.

Authors:  M Ishihara; N S Fedarko; H E Conrad
Journal:  J Biol Chem       Date:  1986-10-15       Impact factor: 5.157

View more
  8 in total

1.  2-O, 3-O Desulfated Heparin Blocks High Mobility Group Box 1 Release by Inhibition of p300 Acetyltransferase Activity.

Authors:  Shuo Zheng; Apparao B Kummarapurugu; Daniel K Afosah; Nehru Viji Sankaranarayanan; Rio S Boothello; Umesh R Desai; Thomas Kennedy; Judith A Voynow
Journal:  Am J Respir Cell Mol Biol       Date:  2017-01       Impact factor: 6.914

2.  Shed syndecan-1 translocates to the nucleus of cells delivering growth factors and inhibiting histone acetylation: a novel mechanism of tumor-host cross-talk.

Authors:  Mark D Stewart; Vishnu C Ramani; Ralph D Sanderson
Journal:  J Biol Chem       Date:  2014-11-17       Impact factor: 5.157

3.  Novel mineralized heparin-gelatin nanoparticles for potential application in tissue engineering of bone.

Authors:  Yuan Yang; Haihao Tang; Alexander Köwitsch; Karsten Mäder; Gerd Hause; Joachim Ulrich; Thomas Groth
Journal:  J Mater Sci Mater Med       Date:  2013-12-06       Impact factor: 3.896

4.  Polymeric fluorescent heparin as one-step FRET substrate of human heparanase.

Authors:  Jyothi C Sistla; Shravan Morla; Al-Humaidi B Alabbas; Ravi C Kalathur; Chetna Sharon; Bhaumik B Patel; Umesh R Desai
Journal:  Carbohydr Polym       Date:  2018-10-28       Impact factor: 9.381

5.  The US regulatory and pharmacopeia response to the global heparin contamination crisis.

Authors:  Anita Y Szajek; Edward Chess; Kristian Johansen; Gyöngyi Gratzl; Elaine Gray; David Keire; Robert J Linhardt; Jian Liu; Tina Morris; Barbara Mulloy; Moheb Nasr; Zachary Shriver; Pearle Torralba; Christian Viskov; Roger Williams; Janet Woodcock; Wesley Workman; Ali Al-Hakim
Journal:  Nat Biotechnol       Date:  2016-06-09       Impact factor: 54.908

Review 6.  Heparan Sulfate Mimetics in Cancer Therapy: The Challenge to Define Structural Determinants and the Relevance of Targets for Optimal Activity.

Authors:  Cinzia Lanzi; Giuliana Cassinelli
Journal:  Molecules       Date:  2018-11-08       Impact factor: 4.411

Review 7.  Glycosaminoglycans as Multifunctional Anti-Elastase and Anti-Inflammatory Drugs in Cystic Fibrosis Lung Disease.

Authors:  Judith A Voynow; Shuo Zheng; Apparao B Kummarapurugu
Journal:  Front Pharmacol       Date:  2020-07-08       Impact factor: 5.810

8.  Dual Action of Sulfated Hyaluronan on Angiogenic Processes in Relation to Vascular Endothelial Growth Factor-A.

Authors:  Linda Koehler; Gloria Ruiz-Gómez; Kanagasabai Balamurugan; Sandra Rother; Joanna Freyse; Stephanie Möller; Matthias Schnabelrauch; Sebastian Köhling; Snezana Djordjevic; Dieter Scharnweber; Jörg Rademann; M Teresa Pisabarro; Vera Hintze
Journal:  Sci Rep       Date:  2019-12-02       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.